ADVICENNE (EPA:ADVIC) | WebDisclosure

Basculer en Français

10411	Companies
217819	Keywords
147368	Articles
115254	Press releases

Home
Companies
ADVICENNE

BRIEF

published on 05/05/2026 at 22:12, 12 days 1 hour ago

Advicenne lance une procédure de sauvegarde pour restructurer sa dette

Restructuration De La Dette Advicenne Procédures De Sauvegarde Secteur Pharmaceutique Sibnayal®
BRIEF

published on 05/05/2026 at 22:12, 12 days 1 hour ago

Advicenne Initiates Safeguard Proceedings to Restructure Debt

Debt Restructuring Advicenne Pharmaceutical Sector Safeguard Proceedings Sibnayal®
PRESS RELEASE

published on 05/05/2026 at 22:07, 12 days 1 hour ago

Informations privilégiées / Autres communiqués
Advicenne annonce l'ouverture d'une procédure de sauvegarde pour restructurer son passif financier et finalise l'extension de son horizon de trésorerie. La société pharmaceutique spécialisée en maladies rénales rares vise à poursuivre ses activités sous protection juridique

Trésorerie Restructuration Procédure De Sauvegarde Endettement Advicenne
PRESS RELEASE

published on 05/05/2026 at 22:07, 12 days 1 hour ago

Inside Information / Other news releases
Advicenne initiates safeguard proceedings to restructure debt and extend cash runway, granted by Paris Commercial Court. Proactive financial restructuring to ensure continuity

Paris Commercial Court Advicenne Cash Runway Restructure Safeguard Proceedings
BRIEF

published on 03/26/2026 at 20:14, 1 month 22 days ago

Advicenne présente ses résultats financiers annuels 2025

Résultats Financiers Croissance Des Ventes Trésorerie Développement Clinique Sibnayal®
BRIEF

published on 03/26/2026 at 20:14, 1 month 22 days ago

Advicenne's 2025 Financial Overview: Mixed Results and Future Prospects

Revenue Growth FDA Approval Advicenne Financial Results 2025 Sibnayal®
BRIEF

published on 03/26/2026 at 20:14, 1 month 22 days ago

Aperçu financier d'Advicenne pour 2025 : Résultats mitigés et perspectives d'avenir

Croissance Des Revenus Approbation De La FDA Advicenne Résultats Financiers 2025 Sibnayal®
BRIEF

published on 03/26/2026 at 20:14, 1 month 22 days ago

Advicenne presents its 2025 annual financial results

Financial Results Treasury Sales Growth Clinical Development Sibnayal®
PRESS RELEASE

published on 03/26/2026 at 20:09, 1 month 22 days ago

Informations privilégiées / Communiqué sur comptes, résultats
Advicenne annonce ses résultats financiers 2025: chiffre d'affaires en hausse, ventes européennes de Sibnayal® en progression, doublement des royalties et horizon de financement à mi T2 2026. Approbation des comptes par le Conseil d'administration

Chiffre D'affaires Résultats Financiers Advicenne Sibnayal® Horizon De Financement
PRESS RELEASE

published on 03/26/2026 at 20:09, 1 month 22 days ago

Inside Information / News release on accounts, results
Advicenne reports its 2025 annual financial results, including a 18.7% increase in product sales, Sibnayal®'s growth in Europe, and the expected US Marketing Authorization. The company aims to extend its cash runway and restructure its balance sheet

Financial Results Advicenne Marketing Authorization Cash Runway Sibnayal

1 2 ... 6

Accesswire

Published on 05/17/2026 at 15:20, 8 hours 10 minutes ago

China XLX Announces 2026 Q1 Results
Published on 05/16/2026 at 01:15, 1 day 22 hours ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 1 day 22 hours ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 1 day 23 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 days ago

Golden Minerals Reports First Quarter 2026 Financial Results

View all ACCESSWIRE

EQS Group

Published on 05/16/2026 at 16:08, 1 day 7 hours ago

The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 3 hours ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 2 days 5 hours ago

Designated Person Notifications
Published on 05/15/2026 at 18:30, 2 days 5 hours ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 2 days 5 hours ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

Les Echos

Published on 05/15/2026 at 15:08, 2 days 8 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 8 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 13 hours ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 14 hours ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 5 hours ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE